US Patent 7667008 Fibroblast growth factor-like polypeptides and variants thereof

Patent 7667008 was granted and assigned to Amgen on February, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Amgen

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7667008

Patent Inventor Names

Arlen Thomason0

Benxian Liu0

Date of Patent

February 23, 2010

Patent Application Number

11733771

Date Filed

April 11, 2007

Patent Citations Received

‌

US Patent 11993637 Modified FGF-21 polypeptides with non-naturally encoded amino acids

‌

US Patent 11667708 Anti-human beta klotho antibody or binding fragment thereof and methods of their use

‌

US Patent 11840558 Methods of treating non-alcoholic steatohepatitis using FGF21 mutants

Patent Primary Examiner

‌

Christine J. Saoud

Patent abstract

The present invention provides novel Fibroblast Growth Factor-like (FGF-like) fusion polypeptides.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7667008 Fibroblast growth factor-like polypeptides and variants thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API